Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.

Clinical trial NCT02712866 · COMPLETED

Trial details

NCT number: NCT02712866
Sponsor: Parc de Salut Mar
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease

Start date: 2017-01-01
Primary completion: 2019-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.